244

Part II Nutrition Assessment, Consequences, and Implications

7. Mason P. Symposium 8: drugs and nutrition. Important drug-nutrient interactions. Proc Nutr Soc. 2010;69(4):551-557.

8. Heuberger RA, Caudell K. Polypharmacy and nutri- tional status in older adults: a cross-sectional study. Drugs Aging. 2011;28(4):315-323.

9. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for poten- tially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-2724.

10. Rumore MM, Vaidean G. Development of a risk assess- ment tool for falls prevention in hospital inpatients based on the medication appropriateness index (MAI) and modified Beer’s Criteria. Innov Pharm. 2012;3(1): 1-12. www.pharmacy.umn.edu/innovations/prod/ groups/cop/@pub/@cop/@innov/documents/article/ cop_article_381617.pdf. Accessed December 29, 2015.

11. Pronsky ZM, Crowe JP. Food Medication Interactions. 17th ed. Birchrunville, PA: Food-Medication Interac- tions; 2012.

12. Pelton R, LaVelle JB, Hawkins EB, Krinsky DL. Drug- Induced Nutrient Depletion Handbook. 2nd ed. Hudson, OH: Lexi-Comp; 2001.

13. Pronksy ZM, Crowe JP. Clinical: food-drug interac- tions. In: Mahan LK, Escott-Stump S, Raymond JL, eds. Krause’s Food & the Nutrition Care Process. 13th ed. St Louis, MO: Elsevier; 2012:209-228.

14. Akamine D, Filho MK, Peres CM. Drug-nutrient inter- actions in elderly people. Curr Opin Clin Nutr Metab Care. 2007;10(3):304-310.

15. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic princi- ples and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14.

16. Saltzman E, Mason J. Enteral nutrition in the elderly. In: Rombeau JL, Rolandelli RH, eds. Clinical Nutri- tion: Enteral and Tube Feeding. 3rd ed. Philadelphia, PA: WB Saunders Co; 1997:385-402.

17. Ahmed T, Haboubi N. Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging. 2010;5:207-216.

18. White JV, Guenter P, Jensen G, Malone A, Schofield M; Academy of Nutrition and Dietetics Malnutrition Work Group; A.S.P.E.N. Malnutrition Task Force; A.S.P.E.N. Board of Directors. Consensus statement of the Acad- emy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: characteristics recom- mended for the identification and documentation of adult malnutrition (undernutrition). J Acad Nutr Diet. 2012;112(5):730-738. doi: 0.1016/j.jand.2012.03.012. Accessed March 24, 2015.

19. Substance Abuse and Mental Health Services Adminis- tration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14–4863. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. www.icpsr. umich.edu/icpsrweb/SAMHDA/support/announce- ments/2014/09/samhsa-releases-results-from-2013. Accessed December 29, 2015.

20. Suter PM. Alcohol: its role in nutrition and health. In: Erdman JW, Macdonald IA, Zeisel SH, eds. Present Knowledge in Nutrition. 10th ed. Hoboken, NJ: Wiley Blackwell; 2012.

21. Alvisa-Negrin J, Gonzalez-Reimer SE, Santolaria-Fer- nandez F, García-Valdecasas-Campelo E, Valls MR, Pelazas-González R, Durán-Castellón MC, de Los Angeles Gómez-Rodríguez M. Osteopenia in alcohol- ics: effect of alcohol abstinence. Alcohol. 2009;44 (5):468–475. doi:10.1093/alcalc/agp038. Accessed March 25, 2015.

22. Guanabens N, Pares A. Liver and bone. Arch Biochem Biophys. 2010;503(1):84-94.

23. Caffeine. WebMD. Natural Medicines Comprehensive Database Consumer Version. www.webmd.com/vita- mins-supplements/ingredientmono-979-caffeine.aspx?a ctiveingredientid=979&activeingredientname=caffeine. Accessed December 29, 2015.

24. Bailey DG, Dresser G, Arnold MO. Grapefruit-medica- tion interactions: forbidden fruit or avoidable conse- quences. CMAJ. 2013;185(4):309–316. www.cmaj.ca/ content/early/2012/11/26/cmaj.120951.full.pdf. Accessed December 29, 2015.

25. Seden MK, Dickinson L, Saye K, Back D. Grapefruit-drug interactions. Drugs. 2010;70(18):2373-2407.

26. Nguyen H, Thompson J, Schutz P, Poch O. Intelligent integrative knowledge bases: bridging genomics, inte- grative biology and translational medicine. In: Holz- inger A, Jurisica I, eds. Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. Berlin: Springer-Verlag Berlin Heidelberg; 2014:255- 270.

27. Pinto N, Dolan ME. Clinically relevant genetic varia- tions in drug metabolizing enzymes. Curr Drug Metab. 2011;12(5):487-497.

28. Boullata JI, Armenti VT. Handbook of Drug-Nutrient Interactions. 2nd ed. Totowa, NJ: Humana Press; 2010.

29. Lamba JK, Lin YS, Schuetz EG, Thummel KE.Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev. 2002;54:1271-1294.

30. Ingelman-Sundberg M. The human genome project and novel aspects of cytochrome P450 research. Toxicol Appl Pharmacol. 2005;207(suppl 2):52-56.

31. Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT. Recommendations for the use of medica- tions with continuous enteral nutrition. Am J Health Syst Pharm. 2009;66(16):1458-1467.

32. Magnuson BL, Clifford TM, Hoskins LA, Bernard AC. Enteral nutrition and drug administration, interactions, and complications. Nutr Clin Pract. 2005;20(6):618- 624.

33. Phelps N. Management of phenytoin with enteral tube feeding. Ment Health Clin. 2012;2(5):108-109.